253 related articles for article (PubMed ID: 3026793)
21. Properties of vasoactive intestinal peptide-receptor interaction in rat liver membranes.
Guerrero JM; Prieto JC; Ramírez-Cárdenas R; Calvo JR; Goberna R
Rev Esp Fisiol; 1981 Mar; 37(1):1-8. PubMed ID: 6113623
[TBL] [Abstract][Full Text] [Related]
22. Study of species specificity in growth hormone-releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors using GRF and intestinal VIP receptors from rat and human: evidence that Ac-Tyr1hGRF is a competitive VIP antagonist in the rat.
Laburthe M; Couvineau A; Rouyer-Fessard C
Mol Pharmacol; 1986 Jan; 29(1):23-7. PubMed ID: 3003561
[TBL] [Abstract][Full Text] [Related]
23. Growth hormone-releasing hormone is produced by rat Leydig cell in culture and acts as a positive regulator of Leydig cell function.
Ciampani T; Fabbri A; Isidori A; Dufau ML
Endocrinology; 1992 Dec; 131(6):2785-92. PubMed ID: 1332849
[TBL] [Abstract][Full Text] [Related]
24. Identification of high affinity receptors for vasoactive intestinal peptide on human lymphocytes of B cell lineage.
O'Dorisio MS; Shannon BT; Fleshman DJ; Campolito LB
J Immunol; 1989 May; 142(10):3533-6. PubMed ID: 2541199
[TBL] [Abstract][Full Text] [Related]
25. Vasoactive intestinal peptide receptor antagonists in rat seminal vesicle membranes.
Rodríguez-Pena MS; Guijarro LG; Prieto JC
Eur J Pharmacol; 1991 Nov; 208(3):207-12. PubMed ID: 1663044
[TBL] [Abstract][Full Text] [Related]
26. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
Gespach C; Bawab W; de Cremoux P; Calvo F
Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
[TBL] [Abstract][Full Text] [Related]
27. Effects of vasoactive intestinal peptide on adenosine 3',5'-monophosphate, ornithine decarboxylase, and cell growth in a human colon cell line.
Yu D; Seitz PK; Selvanayagam P; Rajaraman S; Townsend CM; Cooper CW
Endocrinology; 1992 Sep; 131(3):1188-94. PubMed ID: 1324153
[TBL] [Abstract][Full Text] [Related]
28. VIP receptor subtypes in mouse cerebral cortex: evidence for a differential localization in astrocytes, microvessels and synaptosomal membranes.
Martin JL; Feinstein DL; Yu N; Sorg O; Rossier C; Magistretti PJ
Brain Res; 1992 Jul; 587(1):1-12. PubMed ID: 1326373
[TBL] [Abstract][Full Text] [Related]
29. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
Servin AL; Rouyer-Fessard C; Balasubramaniam A; Saint Pierre S; Laburthe M
Endocrinology; 1989 Feb; 124(2):692-700. PubMed ID: 2536315
[TBL] [Abstract][Full Text] [Related]
30. Vasoactive intestinal peptide receptors in rat liver after partial hepatectomy.
Guijarro LG; Couvineau A; Rodriguez-Pena MS; Juarranz MG; Rodriguez-Henche N; Arilla E; Laburthe M; Prieto JC
Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):515-20. PubMed ID: 1322136
[TBL] [Abstract][Full Text] [Related]
31. The human vasoactive intestinal peptide receptor: molecular identification by covalent cross-linking in colonic epithelium.
Couvineau A; Laburthe M
J Clin Endocrinol Metab; 1985 Jul; 61(1):50-5. PubMed ID: 2987295
[TBL] [Abstract][Full Text] [Related]
32. Solubilization of rat lung vasoactive intestinal peptide receptors in the active state. Characterization of the binding properties and comparison with membrane-bound receptors.
Patthi S; Simerson S; Veliçelebi G
J Biol Chem; 1988 Dec; 263(36):19363-9. PubMed ID: 2848823
[TBL] [Abstract][Full Text] [Related]
33. Cloning and expression of the human vasoactive intestinal peptide receptor.
Sreedharan SP; Robichon A; Peterson KE; Goetzl EJ
Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4986-90. PubMed ID: 1675791
[TBL] [Abstract][Full Text] [Related]
34. Ac-Tyr1hGRF discriminates between VIP receptors from rat liver and intestinal epithelium.
Rouyer-Fessard C; Couvineau A; Voisin T; Laburthe M
Life Sci; 1989; 45(9):829-33. PubMed ID: 2549322
[TBL] [Abstract][Full Text] [Related]
35. Characterization of vasoactive intestinal peptide (VIP) receptors in mammalian lung.
Dickinson KE; Schachter M; Miles CM; Coy DH; Sever PS
Peptides; 1986; 7(5):791-800. PubMed ID: 3025822
[TBL] [Abstract][Full Text] [Related]
36. Effect of gastroduodenostomy on intestinal vasoactive intestinal peptide (VIP) levels, and VIP binding and VIP stimulation of cyclic AMP in intestinal epithelial cells from rat.
Carmena MJ; Prieto JC; Arilla E; Cacicedo L
Biochem Med Metab Biol; 1987 Jun; 37(3):307-13. PubMed ID: 2440464
[TBL] [Abstract][Full Text] [Related]
37. Characterization of vasoactive intestinal peptide receptors in rat seminal vesicle.
Guijarro LG; Rodriguez-Pena MS; Prieto JC
Am J Physiol; 1991 Feb; 260(2 Pt 1):E286-91. PubMed ID: 1847588
[TBL] [Abstract][Full Text] [Related]
38. Characterization of vasoactive intestinal peptide receptors in human colonic epithelial cells.
Broyart JP; Dupont C; Laburthe M; Rosselin G
J Clin Endocrinol Metab; 1981 Apr; 52(4):715-21. PubMed ID: 6259191
[TBL] [Abstract][Full Text] [Related]
39. Interaction of thymic peptide thymosin alpha 1 with vasoactive intestinal peptide (VIP) receptors.
Calvo JR; Goberna R; Guerrero JM
Biosci Rep; 1986 Aug; 6(8):727-33. PubMed ID: 3028522
[TBL] [Abstract][Full Text] [Related]
40. Photoaffinity labelling of the vasoactive-intestinal-peptide-binding site on intact human colonic adenocarcinoma cell line HT29-D4. Synthesis and use of photosensitive vasoactive-intestinal-peptide derivatives.
Martin JM; Darbon H; Luis J; el Battari A; Marvaldi J; Pichon J
Biochem J; 1988 Mar; 250(3):679-85. PubMed ID: 2839143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
